AI-Driven Biomarkers for Antibody-Drug Conjugates (ADC)

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/14/7f/b4/147fb400-2bed-cb44-8ab1-1545164cd302/mza_1941649931504157503.png/600x600bb.jpg

Precision Pathology Podcast (P³)

Perelman School of Medicine, Pathology & Laboratory Medicine

3 episodes

2 weeks ago

Precision Pathology Podcast (P³) features monthly interviews hosted by George J. Netto, MD, Chair of Pathology and Laboratory Medicine at the University of Pennsylvania's Perelman School of Medicine. In each episode, he engages with global thought leaders and authors who are at the forefront of cutting- edge research in pathology and biomedical science. The discussions are easy to follow and highly informative, covering a wide range of groundbreaking technological advancements in precision diagnostics and therapeutics. Topics include digital and computational pathology, single-cell and spatial omics, as well as multiplex biomarker assessment, which are transforming diagnostics, targeted therapies, immunotherapy, and cellular therapeutics.

Health & Fitness

RSS

All content for Precision Pathology Podcast (P³) is the property of Perelman School of Medicine, Pathology & Laboratory Medicine and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Health & Fitness

AI-Driven Biomarkers for Antibody-Drug Conjugates (ADC)

Precision Pathology Podcast (P³)

2 weeks ago

AI-Driven Biomarkers for Antibody-Drug Conjugates (ADC)

In this episode, I discuss with Dr. Salgado, Co-Chair of the International Immuno-Oncology Biomarkers Working Group, his editorial (https://doi.org/10.1016/j.ccell.2025.03.020) on the recent Cancer Cell study by Ding Ma et al, presenting a predictive AI model for HER2-targeting ADC efficacy, incorporating immune system components, hormone receptor status, clinical staging, and HER2+ cell proportion.

#ImmunoOncology
#HER2Biomarker
#AntibodyDrugConjugates